ACTAS UROLOGICAS ESPANOLAS
主办单位：Elsevier Ltd
出版周期：
未知
语种：spa
国际刊号：0210-4806
期刊预警：
不在预警名单中
投稿经验（4）
.jpg)
医脉通用户2956044
2022-06-24 00:23:49
杂志审稿很好，很快。24天后直接接受，效率很高。对要求论文质量较高，编辑也很不错。
.jpg)
医脉通用户4668372
2021-01-14 06:58:16
1个星期就被拒绝了，回复还是挺快的
.jpg)
医脉通用户4396819
2020-09-08 02:14:23
审稿速度为10个月 投稿是否录用被拒
多看、多写、多问、多搜集
.jpg)
医脉通用户1986431
2020-09-02 04:44:03
总的来说是一次不错的投稿体验，从投到接收将近三个月，祝期刊越办越好。
发布我的投稿经验
刊物简介
Actas Urológicas Espaolas is an international journal dedicated to urological diseases and renal transplant. It has been the official publication of the Spanish Urology Association since 1974 and of the American Urology Confederation since 2008. Its articles cover all aspects related to urology.Actas Urológicas Espaolas, governed by the peer review system (double blinded), is published online in Spanish and English. Consequently, manuscripts may be sent in Spanish or English and bidirectional free cost translation will be provided.
最新文章
-
Predictive factors for biochemical recurrence after radical prostatectomy in ISUP Grade Group 1 prostate cancer: a retrospective cohort with long-term follow-up.
ISUP 1 级前列腺癌根治性前列腺切除术后生化复发的预测因素:长期随访的回顾性队列。
-
Effect of mirabegron, tamsulosin, and tadalafil on quality of life in patients with indwelling ureteral (double-J) stents.
米拉贝隆、坦索罗辛和他达拉非对留置输尿管(双 J)支架患者生活质量的影响。
-
Editorial comment on the article «Perioperative and periprocedural management of antithrombotic therapy: 2025 consensus document of SEC, SEDAR, SEACV, SECCE, AEC, SECOM CYC, SECPRE, SEPD, SEGG, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEN, S.E.N., SENEC, SEPAR, SEO, SEORL-CCC, SEPA, SERVEI, SECOT, and AEU».
编辑对文章“抗血栓治疗的围手术期和围手术期管理:SEC、SEDAR、SEACV、SECCE、AEC、SECOM CYC、SECPRE、SEPD、SEGG、SEGO、SEHH、SETH、SEMERGEN、SEMFYC、SEMG、SEMICYUC、SEMI、SEMES、SEN、SENN、SENEC、SEPAR、SEO、SEORL-CCC、SEPA、SERVEI、SECOT和AEU的2025年共识文件”发表评论。
